Efficacy and safety of Ongericimab in patients with hypercholesterolemia: a systematic review and meta-analysis
{{output}}
Background: Hypercholesterolemia represents abnormally elevated cholesterol levels and constitutes a major modifiable risk factor for cardiovascular diseases (CVDs). Low-density lipoprotein cholesterol (LDL-C) reduction remains t... ...
